StockGlow

Thalia Therapeutics Plc (0GO.F)

Thalia Therapeutics Plc, a biotechnology company, develops and delivers RNA-based therapeutics and technologies in oncology and cardiovascular disease in the United Kingdom.

0.00+0.00%Healthcare
Compare 0GO.F with
StockGlow Score
4
Bearish
BearishBullish
1 year ago+0.0%

The outlook

Thalia Therapeutics Plc currently reads as bearish based on below its 50- & 200-day averages, 2% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range2% of the way from its 52-week low to high
Market cap
$1.8M
52-wk high
0.03
52-wk low
0.00
50-day avg
0.00
200-day avg
0.00
Trailing P/E
—

Similar stocks

0EH.FARCHION Corporation$1.38-0.79%0ET.MUEsperion Therapeutics Inc$2.76+0.00%0ET.DUEsperion Therapeutics Inc$2.78+0.00%0GM.DUgraceNT AG$0.52+0.00%0AF.FOdinwell AB (publ)$0.01-13.75%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy